Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism

Journal of Nuclear Medicine

Volumn 49, Issue 5, 2008, Pages 700-707

  Frost, Michelle L ^a,f   Blake, Glen M ^a   Park Holohan, So Jin ^b   Cook, Gary J R ^c   Curran, Kathleen M ^d   Marsden, Paul K ^e   Fogelman, Ignac ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

18F fluoride PET; Bone metabolism; Osteoporosis; Precision

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; FLUORINE 18; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; COMPARTMENT MODEL; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LUMBAR SPINE; NONLINEAR REGRESSION ANALYSIS; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; KINETICS; LUMBAR VERTEBRAE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSTMENOPAUSE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 44149086406     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.046987     Document Type: Article

References (30)

1. 18F-fluoride positron emission tomography in postmenopausal women. J Bone Miner Res. 2000;15:763-769.
2. 18F- fluoride positron emission tomography. J Bone Miner Res. 2002;17:854-859.
3. 18F-fluoride positron emission tomography. J Bone Miner Res. 2003;18:2215-2222.
4. Frost ML, Fogelman I, Blake GM, Marsden PK, Fogelman I. 2004 dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis. J Bone Miner Res. 2004;19:1797-1804.
5. 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover. J Clin Densitom. 2006;10:46-54.
6. 18F-fluoride PET scans. J Nucl Med. 2004;45:1493-1500.
7. Hawkins RA, Choi Y, Huang S-C, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med. 1992;33:633-642.
8. 18F-Fluoride PET for monitoring therapeutic response in Paget's disease of bone. J Nucl Med. 2005;46:1650-1658.
9. 18F-fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab. 1993;77:949-955.
10. 18F-fluoride PET: correlation with bone histomorphometry. J Nucl Med. 2001;42:1091-1100.
11. 18F-fluoride ion PET and quantitative CT. J Nucl Med. 2003;44:117-124.
12. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med. 1997;38:1970-1976.
13. Hallett WA. Quantification in clinical fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 2004;25:647-650.
14. Marsden PK. Quantification in PET: what is it? Can we do it? Do we need it? Nucl Med Commun. 2004;25:635-636.
15. Garnero P, Sornay-Rendu E, Duboef F, Delmas PD. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int. 1999;11(suppl 6):55-65.
16. 18F]fluoride ion positron emission tomography. Eur J Nucl Med. 1999;26:615-624.
17. Schliephake H, Berding G, Knapp WH, Sewilam S. Monitoring of graft perfusion and osteoblast activity in revascularised fibula segments using [18F]-positron emission tomography. Int J Oral Maxillofac Surg. 1999;28:349-355.
18. Sorensen J, Ullmark G, Langstrom B, Nilsson O. Rapid bone and blood flow formation in impacted morselized allografts: positron emission tomography (PET) studies on allografts in 5 femoral component revisions of total hip arthroplasty. Acta Orthop Scand. 2003;74:633-643.
19. Blake GM, Fogelman I. Interpretation of bone densitometry studies. Semin Nucl Med. 1997;27:248-260.
20. World Health Organisation. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Geneva, Switzerland: WHO; 1999. Technical support series no. 843.
21. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468-489.
22. Cook GJR, Lodge MA, Marsden PK, Dynes A, Fogelman I. Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med. 1999;26:1424-1429.
23. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
24. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab. 1985;5:584-590.
25. 18F-fluoride ion positron emission tomography. Eur J Nucl Med Mol Imaging. 2002;29:907-914.
26. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission tomography: 1. Effect of object size. J Comput Assist Tomogr. 1979;3:299-308.
27. Weber WA, Ziegler SI, Thodtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med. 1999;40:1771-1777.
28. 18F-FDG PET. J Nucl Med. 2002;43:1304-1309.
29. Krak NC, Hoekstra OS, Lammertsma AA. Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations. Eur J Nucl Med Mol Imaging. 2004;31(suppl 1):103-111.
30. Visvikis D, Turzo A, Bizais Y, Cheze-Le Rest C. Technology related parameters affecting quantification in positron emission tomography imaging. Nucl Med Commun. 2004;25:637-641.